Predicting anti-HIV-1 activity of 6-arylbenzonitriles: Computational approach using superaugmented eccentric connectivity topochemical indices

Journal of Molecular Graphics and Modelling

Volumn 26, Issue 6, 2008, Pages 1020-1029

  Dureja, Harish ^a   Gupta, Sunil ^b   Madan, A K ^a  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

6 Arylbenzonitriles; Anti HIV 1 activity; Structure activity relationship; Superaugmented eccentric connectivity topochemical index; Topochemical indices

Indexed keywords

BIOACTIVITY; DATA STRUCTURES; ISOMERS; MATHEMATICAL MODELS; OPTIMIZATION;

6-ARYLBENZONITRILES; ECCENTRIC CONNECTIVITY; HETEROATOMS; TOPOCHEMICAL INDICES;

VIRUSES;

BENZONITRILE;

ANTIVIRAL ACTIVITY; ARTICLE; COMBINATORIAL LIBRARY; COMPUTER PROGRAM; DRUG DESIGN; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOMER; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTITATIVE STRUCTURE PROPERTY RELATION;

ANTI-HIV AGENTS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; MODELS, CHEMICAL; MODELS, MOLECULAR; NITRILES; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 37349040711     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2007.08.008     Document Type: Article

References (25)

1. Estrada E., and Uriarte E. Recent advances on the role of topological indices in drug discovery research. Curr. Med. Chem. 8 (2001) 1573-1588
2. Roy K. Topological descriptors in drug design and modeling studies. Mol. Diver. 8 (2004) 321-323
3. Basak S.C. Use of molecular complexity indices in predictive pharmacology and toxicology: a QSAR approach. Med. Sci. Res. 15 (1987) 605-609
4. Estrada E., Ivanciuc O., Gutman I., Gutierrez A., and Rodriguez L. Extended Wiener indices. A new set of descriptors for quantitative structure-property studies. New J. Chem. 22 (1998) 819-822
5. Balaban A.T., Beteringhe A., Constantinescu T., Filip P.A., and Ivanciuc O. Four new topological indices based on the molecular path code. J. Chem. Inf. Model. 47 (2007) 716-731
6. Estrada E., Patlewicz G., and Uriarte E. From molecular graphs to drugs. A review on the use of topological indices in drug design and discovery. Indian J. Chem. 42A (2003) 1315-1329
7. Basak S.C., Gute B.D., and Grunwald G.D. Use of topostructural, topochemical, and geometric parameters in the prediction of vapor pressure: a hierarchical QSAR approach. J. Chem. Inf. Comput. Sci. 37 (1997) 651-655
8. Musah R.A. The HIV-1 nucleocapsid zinc finger protein as a target of antiretroviral therapy. Curr. Med. Chem. 4 (2004) 1605-1622
9. De Clercq E. Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS). J. Med. Chem. 29 (1986) 1561-1569
10. Mitsuya H., Weinhold K.J., Furman P.A., St Clair M.H., Lehrman S.N., Gallo R.C., Bolognesi D., Barry D.W., and Broder S. 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 7096-7100
11. Mitsuya H., and Broder S. Strategies for antiviral therapy in AIDS. Nature 325 (1987) 773-778
12. Ludovici D.W., De Corte B.L., Kukla M.J., Ye H., Ho C.Y., Lichtenstein M.A., Kavash R.W., Andries K., de Bethune M.P., Azijn H., Pauwels R., Lewi P.J., Heeres J., Koymans L.M., de Jonge M.R., Van Aken K.J., Daeyaert F.F., Das K., Arnold E., and Janssen P.A. Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues. Bioorg. Med. Chem. Lett. 11 (2001) 2235-2239
13. Richman D.D. HIV drug resistance. AIDS Res. Human Retroviruses 8 (1992) 1065-1071
14. Larder B.A., and Kemp S.D. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to Zidovudine (AZT). Science 246 (1989) 1155-1158
15. De Clercq E., and Holy A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat. Rev. Drug Discov. 4 (2005) 928-940
16. Turpin J.A., Song Y., Inman J.K., Huang M., Wallqvist A., Maynard A., Covell D.G., Rice W.G., and Appella E. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers. J. Med. Chem. 42 (1999) 67-86
17. De Clercq E. Novel compounds in preclinical/early clinical development for the treatment of HIV infections. Rev. Med. Virol. 10 (2000) 255-277
18. Moore J.P., and Stevenson M. New targets for inhibitors of HIV-1 replication. Natl. Rev. Mol. Cell. Biol. 1 (2000) 40-49
19. Chan J.H., Hong J.S., Hunter III R.N., Orr G.F., Cowan J.R., Sherman D.B., Sparks S.M., Reitter B.E., Andrews III C.W., Hazen R.J., Clair M.S., Boone L.R., Ferris R.G., Creech K.L., Roberts G.B., Short S.A., Weaver K., Ott R.J., Ren J., Hopkins A., Stuart D.I., and Stammers D.K. 2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1. J. Med. Chem. 44 (2001) 1866-1882
20. Gupta S., Singh M., and Madan A.K. Predicting anti-HIV activity: computational approach using novel topological descriptor. J. Comput. Aid. Mol. Des. 15 (2000) 671-678
21. Ivanciuc O., Ivanciuc T., Klein D.J., Seitz W.A., and Balaban A.T. Wiener index extension by counting even/odd graph distances. J. Chem. Inf. Comput. Sci. 41 (2001) 536-549
22. Gozalbes R., Doucet J., and Derouin F. Application of topological descriptors in QSAR and drug design: history and new trends. Curr. Drug Targets Infect. Disord. 2 (2002) 93-102
23. Balaban A.T. Using real numbers as vertex invariants for third-generation topological indexes. J. Chem. Inf. Comput. Sci. 32 (1992) 23-28
24. Bajaj S., Sambi S.S., and Madan A.K. Model for prediction of anti-HIV activity of 2-pyridinone derivatives using novel topological descriptor. QSAR Comb. Sci. 25 (2006) 813-823
25. 2A receptor antagonistic activity of arylindoles: computational approach using topochemical descriptors. J. Mol. Graph. Model. 25 (2006) 373-379